WuXi Biologics (Cayman) (MEX:2269) Net Issuance of Preferred Stock : MXN0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is WuXi Biologics (Cayman) Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

WuXi Biologics (Cayman)'s net issuance of preferred for the six months ended in Dec. 2024 was MXN0 Mil. The number is 0, which means that WuXi Biologics (Cayman) has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

WuXi Biologics (Cayman)'s net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2024 was MXN0 Mil.

WuXi Biologics (Cayman) Net Issuance of Preferred Stock Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Net Issuance of Preferred Stock Chart

WuXi Biologics (Cayman) Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

WuXi Biologics (Cayman) Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

WuXi Biologics (Cayman) Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was MXN0 Mil.

WuXi Biologics (Cayman) Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi Biologics (Cayman) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (MEX:2269) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

WXIBF:USA WXXWY:USA 02269:Hong Kong 1FW2:Germany

Address

No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092

Website

https://www.wuxibiologics.com

WuXi Biologics is one of the largest global biologic global contract development and manufacturing organizations. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 18.7 billion. North America represented 57.3% of total revenue in 2024. The firm has a "follow and win the molecule" strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual sourcing strategy by providing drug products and drug substance manufacturing.

WuXi Biologics (Cayman) Headlines

No Headlines